Solid Biosciences Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Charlestown, MA
SLDB chart
What traders are saying about $SLDB
Latest postsSolid Biosciences Inc. news
- William Blair Initiates Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $11
Moomoo ·
- William Blair assumes coverage of Solid Biosciences at Outperform
TradingView ·
- Solid Biosciences a new Outperform at William Blair on Duchenne asset
Seeking Alpha ·
- Weekly Recap: Q3 $53.9 million loss and first Phase 3 SGT-003 dose
TradingView ·
- Form 13D/A SOLID BIOSCIENCES INC. For: 7 November By Investing.com
Investing.com Australia ·
- Dilution, not trading, changes RA Capital's reported stake in Solid Biosciences (SLDB).
Stock Titan ·
- Wedbush Maintains Solid Biosciences(SLDB.US) With Buy Rating, Cuts Target Price to $15
Moomoo ·
- Solid Biosciences Inc. (SLDB) Seasonal returns chart
Yahoo Finance UK ·
- Solid Biosciences to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Yahoo Finance ·
- Solid Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Solid Biosciences reports Q3 2026 earnings and issues business update
Traders Union ·
- Solid Biosciences Reports Third Quarter 2026 Financial Results and Provides Business Updates
Yahoo Finance ·
Solid Biosciences Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $8.1M |
| Net income | – | – | – | – |
| Diluted EPS | $-1.99 | $-3.06 | $-4.83 | $-10.10 |
| Total assets (year end) | $232.5M | $188.7M | $164.9M | $260.3M |
| Cash and equivalents (year end) | $59.9M | $80.2M | $74.0M | $155.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Solid Biosciences Inc.
- Ticker
- SLDB (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Charlestown, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1707502
- Former names
- Solid Biosciences, LLC
Frequently asked questions
What exchange is Solid Biosciences Inc. listed on?
Solid Biosciences Inc. trades on the Nasdaq under the ticker symbol SLDB.
What industry is Solid Biosciences Inc. in?
Solid Biosciences Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Solid Biosciences Inc. headquartered?
Solid Biosciences Inc.'s business address on file with the SEC is in Charlestown, MA.
When does Solid Biosciences Inc.'s fiscal year end?
Solid Biosciences Inc.'s fiscal year ends on December 31.
How much revenue did Solid Biosciences Inc. report?
Solid Biosciences Inc. reported $8.1M in revenue for calendar year 2022, according to its SEC filings.